Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT

v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - 9 months ended Sep. 30, 2018 - USD ($)
Common Stock
Additional Paid-In Capital
Subscriptions Receivable
Accumulated Deficit
Total
Balances at beginning at Dec. 31, 2017 $ 1,679 $ 12,383,506 $ (20,384,478) $ (7,999,293)
Balances at beginning (in shares) at Dec. 31, 2017 16,797,744        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of shares in private placement $ 665 4,031 (1,958) 2,738
Issuance of shares in private placement (in shares) 6,648,586        
Issuance of shares in conversion of debt $ 202 120,369 120,571
Issuance of shares in conversion of debt (in shares) 2,017,402        
Recovery of derivative liability 1,742,939 1,742,939
Effect of merger and recapitalization pursuant to execution of Agreement and Plan of Merger and Reorganization $ 2,500 83,725 86,225
Effect of merger and recapitalization pursuant to execution of Agreement and Plan of Merger and Reorganization (in shares) 25,000,000        
Net loss (3,848,894) (3,848,894)
Balances at ending at Sep. 30, 2018 $ 5,046 $ 14,334,570 $ (1,958) $ (24,233,372) $ (9,895,714)
Balances at ending (in shares) at Sep. 30, 2018 50,463,732